Pharmaceutical Controversies and the Performative Value of Uncertainty
In September 2004, the global pharmaceutical manufacturer Merck & Co. removed Vioxx from the US market. The company soon faced almost 30,000 lawsuits over the alleged concealment of adverse effects. Despite suspicions that the Vioxx scandal would cripple the company's profitability, Mer...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Published: |
2009
|